Screener
CorMedix CRMD Shares (Diluted)
Discontinued — last reported Q1 '26
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Unrealized loss from investments | (1) | (5) |
| Foreign currency translation loss | - | (1) |
| Total Other Comprehensive Loss | (1) | (6) |
| Comprehensive Income | $38,600 | $20,638 |
| Net Income Per Common Share – Basic | $0.48 | $0.32 |
| Net Income Per Common Share - Diluted | $0.43 | $0.30 |
| Weighted Average Common Shares Outstanding – Basic | 79,509 | 65,244 |
| Weighted Average Common Shares Outstanding – Diluted | 92,985 | 68,975 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's shares (diluted)?
- CorMedix (CRMD) reported shares (diluted) of 93M in Q1 2026.
- How has CorMedix's shares (diluted) changed year-over-year?
- CorMedix's shares (diluted) increased by 34.8% year-over-year, from 69M to 93M.
- What is the long-term trend for CorMedix's shares (diluted)?
- Over 4 years (2021 to 2025), CorMedix's shares (diluted) has grown at a 19.6% compound annual growth rate (CAGR), from 150.2M to 307.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about CorMedix's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude